Last updated:
ID:
748685
Start date:
16 July 2025
Project status:
Current
Principal investigator:
Professor Kin Fai Ho
Lead institution:
Chinese University of Hong Kong, China

Understanding human diseases’ complex etiology necessitates a comprehensive approach that integrates diverse data sources. Diseases arise from intricate interactions among genetic, environmental, and lifestyle factors, which traditional single-dimensional studies often overlook. Advancements in high-throughput technologies have produced extensive datasets across various domains, including genetic, metabolic, proteomic, and clinical data. By integrating these datasets and utilizing advanced bioinformatics and statistical methods, we can uncover insights into disease mechanisms, identify key interactions and pathways, and improve strategies for prevention and diagnosis.
Research Objectives:
1. Develop a Multidimensional Disease Model: Integrate UK Biobank’s genetic, imaging, biochemical (e.g., metabolomics, proteomics), and lifestyle data to map interactions driving human diseases.
2. Decode Health Disparity Mechanisms: Quantify how environmental stressors (e.g., urbanicity, air pollution) and socioeconomic factors modulate genetic risk.
3. Biomarker Discovery and Predictive Model Development: Identify novel biomarkers and develop predictive models for early disease detection and personalized interventions.
Scientific Rationale:
UK Biobank’s unique strength lies in its large-scale multimodal data, including rare imaging phenotypes, longitudinal EHR linkages, and geospatial environmental data. This enables three key advances:
1. Mechanistic Insight: Combining imaging with genomics, metabolomics, and proteomics can reveal how environmental triggers activate genetic risks.
2. Precision Prevention: Identifying subgroups with high genetic risk but modifiable lifestyle profiles allow targeted interventions.
3. Equity in Biomedicine: UK Biobank’s detailed socioeconomic data addresses a critical gap in understanding why health disparities persist despite similar genetic risks.